Hellodolly1

Inovio Pharmaceuticals - Short term not only COVID

看多
NASDAQ:INO   Inovio Pharmaceuticals, Inc.
Next 45 days packed with potential catalysts -
Friday ASCO poster with REGN regarding 2nd Cohort 85% 12 Month OS, Glioblastoma GBM
Results from COVID animal challenge data on ferrets and monkeys, (mice and guinea pigs published last week),
CEPI funding announcement, WHO, GATTES?
COVID PHII announcements in Korea and China,
FDA Approval PHII U.S.,
Inclusion in Warp Speed announcement,
Prostate Trials - Parker Institute

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。